A Review of Acquired Autoimmune Blistering Diseases in Inherited Epidermolysis Bullosa: Implications for the Future of Gene Therapy
Gene therapy serves as a promising therapy in the pipeline for treatment of epidermolysis bullosa (EB). However, with great promise, the risk of autoimmunity must be considered. While EB is a group of inherited blistering disorders caused by mutations in various skin proteins, autoimmune blistering...
Main Authors: | Payal M. Patel, Virginia A. Jones, Christy T. Behnam, Giovanni Di Zenzo, Kyle T. Amber |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Antibodies |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4468/10/2/19 |
Similar Items
-
Autoimmunity and Cytokine Imbalance in Inherited Epidermolysis Bullosa
by: Susanna Esposito, et al.
Published: (2016-09-01) -
Dystrophic epidermolysis bullosa in a child
by: Uma Eswara
Published: (2012-01-01) -
Severe generalized junctional epidermolysis bullosa in a newborn
by: Rekha Thaddanee, et al.
Published: (2021-10-01) -
Variable Outcome of Immunotherapy in Advanced Multiple Cutaneous Squamous Cell Carcinomas in Two Patients with Recessive Dystrophic Epidermolysis Bullosa
by: Laura Trefzer, et al.
Published: (2023-06-01) -
“Quality of Life in Epidermolysis Bullosa” and “Epidermolysis Bullosa Burden of Disease”: Italian translation, cultural adaptation, and pilot testing of two disease-specific questionnaires
by: May El Hachem, et al.
Published: (2024-04-01)